Delivery Order SPE2DR25D1100-SPE2DR26FCP6F
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $18,423.65 by the Defense Logistics Agency on September 8, 2025, for the supply of Orencia ClickJect 125 mg/mL. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 9, 2025. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,954.49 by the Defense Logistics Agency (DLA) on September 23, 2025, for the supply of Orencia ClickJect 125 mg/mL, a biologic medication used to treat rheumatoid arthritis and other autoimmune conditions. This competitively awarded, firm fixed-price delivery order is set to be completed by September 24, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitively competed delivery order valued at $14,336.86 by the Defense Logistics Agency on July 14, 2025, with an ultimate completion date of July 15, 2025. The order is for Orencia Clickjet 125 mg/mL, a specialty pharmaceutical product, under firm fixed price terms with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $28,752.32 for Orencia ClickJect 125 mg/ml on September 24, 2025. This non-competitive, firm fixed-price delivery order was funded through the Defense Logistics Agency's Medical Supply Chain and is set to be completed by September 25, 2025. The delivery will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,601.12 by the Defense Logistics Agency on July 11, 2025, for the supply of Orencia ClickJect 125 mg/ml, a pharmaceutical product used in immunological and rheumatologic treatments. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and was awarded through open competition without set-aside designation. This award is a...
- The Defense Logistics Agency awarded a $37,093.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Orencia ClickJect 125 mg/ml. The contract, which is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), requires performance completion by October 23, 2025. This delivery order was competitively awarded with no set-aside designation...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Orencia ClickJect 125 mg/mL, a pharmaceutical product used in the treatment of rheumatoid arthritis and other autoimmune conditions. This firm fixed-price delivery order, valued at $16,118.84, is classified as a non-set-aside contract and represents a competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $44,294.54 by the Defense Logistics Agency on November 17, 2025, for the supply of Orencia Clickject 125 mg/ml. This is a firm fixed price, non-set-aside contract with an ultimate completion date of November 18, 2025. The award represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $38,478.55 delivery order to AmerisourceBergen Drug Corp for Orencia ClickJect 125 mg/ml, a rheumatoid arthritis treatment. This competitively awarded, firm fixed-price delivery order was issued on April 21, 2025, with an ultimate completion date of April 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) for Orencia 125 mg/mL syringes valued at $8,646.31. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, under firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction processed through the company's existing Indefinite...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCP6FDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,787.56 by the Defense Logistics Agency on November 17, 2025, for the supply of Orencia ClickJect 125 mg/mL. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The contract contains no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order falls within AmerisourceBergen's extensive portfolio of federal medical procurement contracts with the Defense Logistics Agency, which supply pharmaceutical products and medical devices to support military healthcare systems and defense operations. Orencia (abatacept) is a biologic immunosuppressant used in the treatment of rheumatoid arthritis and other autoimmune conditions, reflecting the company's role in providing specialized therapeutic medications to the military health system. The DLA Troop Support Medical IDC enables AmerisourceBergen to fulfill ongoing federal medical supply requirements across multiple therapeutic domains on a global basis, serving customers including the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/17/25 |